Prolonged pharmacotherapy and the eye. A symposium. Opening remarks.
D000221:Adaptation, Ocular; D002738:Chloroquine / Q000009:adverse effects; D003624:Darkness; D064420:Drug-Related Side Effects and Adverse Reactions; D005123:Eye / Q000187:drug effects*; D005246:Feedback; D005260:Female; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D008027:Light; D008297:Male; D008543:Melanins / Q000502:physiology*; D009411:Nerve Endings / Q000187:drug effects; D009799:Ocular Physiological Phenomena; D010640:Phenothiazines / Q000009:adverse effects; D010858:Pigmentation; D010870:Pineal Gland / Q000187:drug effects*; D012168:Retinal Pigments; D011984:Sensory Receptor Cells; D014149:Tranquilizing Agents / Q000009:adverse effects; D014785:Vision, Ocular / Q000187:drug effects*
D008543:Melanins; D010640:Phenothiazines; D012168:Retinal Pigments; D014149:Tranquilizing Agents; D002738:Chloroquine